Cargando…

Preclinical Remodeling of Human Prostate Cancer through the PTEN/AKT Pathway

Knowledge gained from the identification of genetic and epigenetic alterations that contribute to the progression of prostate cancer in humans is now being implemented in the development of functionally relevant translational models. GEM (genetically modified mouse) models are being developed to inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Velasco, Marco A., Uemura, Hirotsugu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290809/ https://www.ncbi.nlm.nih.gov/pubmed/22454635 http://dx.doi.org/10.1155/2012/419348

Ejemplares similares

Efficacy of targeted AKT inhibition in genetically engineered mouse models of PTEN-deficient prostate cancer
por: De Velasco, Marco A., et al.
Publicado: (2016)

Context-Specific Efficacy of Apalutamide Therapy in Preclinical Models of Pten-Deficient Prostate Cancer
por: De Velasco, Marco A., et al.
Publicado: (2021)

Evaluation of in vivo responses of sorafenib therapy in a preclinical mouse model of PTEN-deficient of prostate cancer
por: Yamamoto, Yutaka, et al.
Publicado: (2015)

The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome
por: Fujita, Kazutoshi, et al.
Publicado: (2023)

Androgen deprivation induces phenotypic plasticity and promotes resistance to molecular targeted therapy in a PTEN-deficient mouse model of prostate cancer
por: De Velasco, Marco A., et al.
Publicado: (2014)

circPTEN suppresses colorectal cancer progression through regulating PTEN/AKT pathway
por: Li, Chen, et al.
Publicado: (2021)

Emerging Relationship between the Gut Microbiome and Prostate Cancer
por: Matsushita, Makoto, et al.
Publicado: (2023)

Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines
por: Wang, Yu, et al.
Publicado: (2010)

miR-92a promotes proliferation and inhibits apoptosis of prostate cancer cells through the PTEN/Akt signaling pathway
por: Yanshen, Zheng, et al.
Publicado: (2021)

The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer
por: Turnham, Daniel J., et al.
Publicado: (2020)

Correction: MiR-146b inhibits autophagy in prostate cancer through affecting PTEN/AKT/mTOR signaling pathway
por: Gao, Song, et al.
Publicado: (2019)

PTBP1 promotes the growth of breast cancer cells through the PTEN/Akt pathway and autophagy
por: Wang, Xu, et al.
Publicado: (2018)

PTEN inhibitor improves vascular remodeling and cardiac function after myocardial infarction through PI3k/Akt/VEGF signaling pathway
por: Feng, Qiuting, et al.
Publicado: (2020)

PTEN regulation of the proliferation and differentiation of auditory progenitors through the PTEN/PI3K/Akt-signaling pathway in mice
por: Sun, Chen, et al.
Publicado: (2014)

FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis
por: Seshacharyulu, Parthasarathy, et al.
Publicado: (2019)

MiR-21 promotes pterygium cell proliferation through the PTEN/AKT pathway
por: Li, Xia, et al.
Publicado: (2018)

MiR-146b inhibits autophagy in prostate cancer by targeting the PTEN/Akt/mTOR signaling pathway
por: Gao, Song, et al.
Publicado: (2018)

Connecting the Dots Between the Gut–IGF-1–Prostate Axis: A Role of IGF-1 in Prostate Carcinogenesis
por: Matsushita, Makoto, et al.
Publicado: (2022)

PTEN‐AKT pathway attenuates apoptosis and adverse remodeling in ponatinib‐induced skeletal muscle toxicity following BMP‐7 treatment
por: Srivastava, Ayushi, et al.
Publicado: (2023)

The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN
por: Egawa, Hiroshi, et al.
Publicado: (2016)

FAM46C inhibits cell proliferation and cell cycle progression and promotes apoptosis through PTEN/AKT signaling pathway and is associated with chemosensitivity in prostate cancer
por: Ma, Libin, et al.
Publicado: (2020)

The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models
por: Carnero, Amancio, et al.
Publicado: (2014)

Association of polymorphisms of PTEN, AKT1, PI3K, AR, and AMACR genes in patients with prostate cancer
por: de Nóbrega, Monyse, et al.
Publicado: (2020)

Dichloroacetate Overcomes Oxaliplatin Chemoresistance in Colorectal Cancer through the miR-543/PTEN/Akt/mTOR Pathway
por: Liang, Yu, et al.
Publicado: (2019)

Berberine Reverses Doxorubicin Resistance by Inhibiting Autophagy Through the PTEN/Akt/mTOR Signaling Pathway in Breast Cancer
por: Wang, Ye, et al.
Publicado: (2020)

TSPAN7 Exerts Anti-Tumor Effects in Bladder Cancer Through the PTEN/PI3K/AKT Pathway
por: Yu, Xi, et al.
Publicado: (2021)

Telomerase reverse transcriptase induced thyroid carcinoma cell proliferation through PTEN/AKT signaling pathway
por: Zhang, Hao, et al.
Publicado: (2018)

AQP8 promotes glioma proliferation and growth, possibly through the ROS/PTEN/AKT signaling pathway
por: Hao, Zhang, et al.
Publicado: (2023)

Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
por: Chappell, William H., et al.
Publicado: (2011)

Exosomes promote cetuximab resistance via the PTEN/Akt pathway in colon cancer cells
por: Zhang, S., et al.
Publicado: (2017)

Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer
por: Nip, Hannah, et al.
Publicado: (2016)

LncRNA PlncRNA-1 accelerates the progression of prostate cancer by regulating PTEN/Akt axis
por: Cui, Zilian, et al.
Publicado: (2021)

Dysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN()()
por: Nakakido, Makoto, et al.
Publicado: (2015)

Columbamine-Mediated PTEN/AKT Signal Pathway Regulates the Progression of Glioma
por: Niu, Hai-Tao, et al.
Publicado: (2021)

Inhibition of the AKT/mTOR pathway negatively regulates PTEN expression via miRNAs: Effect of Akt/mTOR inhibition on PTEN expression
por: Wan, Linyan, et al.
Publicado: (2022)

Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention
por: Davis, Nicole M., et al.
Publicado: (2014)

PLZF Mediates the PTEN/AKT/FOXO3a Signaling in Suppression of Prostate Tumorigenesis
por: Cao, JingPing, et al.
Publicado: (2013)

Genomic Rearrangements of PTEN in Prostate Cancer
por: Phin, Sopheap, et al.
Publicado: (2013)

Knockdown of Phospholipase Cɛ (PLCɛ) Inhibits Cell Proliferation via Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN)/AKT Signaling Pathway in Human Prostate Cancer
por: Wang, Xiao, et al.
Publicado: (2018)

PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN
por: Xiong, Jianbo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_j5calmpnrernebtfqpem5250di